Lyrica: latest news - GoINPHARMA
Monday, 10 December 2018 - 14:17

Lyrica

Pfizer: FDA approves Lyrica CR

Pfizer has announced that FDA has approved Lyrica CR (pregabalin) extended-release tablets as once-daily therapy for the management of neuropathic pain associated with diabetic neuropathy and the management of postherpetic neuralgia. The drug has not received approval for the management…

Pfizer’s Lyrica in pediatric epilepsy, positive Phase III results

Pfizer today announced positive results from a Phase-III clinical trial aimed at evaluating the use of Lyrica (pregabalin) capsules and oral solution as adjunctive therapy for pediatric epilepsy in patients between 4 and 16 years of age. Adjunctive treatment with…

Pfizer must seek a mega-merger to keep growing

Pfizer’s shares have declined over 10% since August, while the Healthcare sector has only lost 5%, although Pfizer has been fairly active in M&A since August, having acquired Medivation ($14) and AstraZeneca’s antibiotic portfolio ($1.5bn). Besides, Pfizer announced in September…